[{"Assets_0_Q2_USD":542638000.0,"CommonStockSharesOutstanding_0_Q2_shares":70969000.0,"EarningsPerShareBasic_1_Q2_USD":-0.48,"EarningsPerShareBasic_2_Q2_USD":-0.99,"EarningsPerShareDiluted_1_Q2_USD":-0.48,"EarningsPerShareDiluted_2_Q2_USD":-0.99,"NetIncomeLoss_1_Q2_USD":-33183000.0,"NetIncomeLoss_2_Q2_USD":-66344000.0,"StockholdersEquity_0_Q2_USD":230098000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":69638000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":66853000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":69638000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":66853000.0,"Ticker":"FGEN","CIK":"921299","name":"FIBROGEN INC","OfficialName":"FibroGen Inc Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"987680900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170807"}]